Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 1/20 | 0.55 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.48 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.35 |
| ▸ | ANPEP | P15144 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4538237 | 0.92 | TYMS (0.58) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL5486639 | 0.80 | TYMS (0.47) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL20235 | 0.80 | TYMS (0.85) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL26037359 | 0.77 | S1PR2 (0.47) | TYMSLMNACYP3A4NFKB1BLM | |
| SCHEMBL3211535 | 0.76 | TYMS (0.79) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL767546 | 0.76 | TYMS (0.79) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL1636300 | 0.76 | TYMS (0.79) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL7902534 | 0.76 | TYMS (0.79) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL9701682 | 0.76 | TYMS (0.79) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| Ammonia Solution, Strong SCHEMBL2319488 | 0.76 | TYMS (0.79) | TYMSLPAR3LPAR2LMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250277134-A1 | SILANE MODIFICATION OF CERIA NANOPARTICLES IN COLLOIDALLY STABLE SOLUTIONS | CMC MATERIALS LLC | 2025-09-04 | — | — | US | claimed |
| US-12371550-B2 | Method for fabricating nano-particle having perovskite crystalline structure and resin composition including the nano-particle | KOREA INSTITUTE OF MACHINERY & MATERIALS (KR) | 2025-07-29 | — | — | US | claimed |
| CN-113874318-B | Method for obtaining mesoporous silica particle-supported metal oxides | 柏林工业大学 | 2024-05-07 | — | — | CN | claimed |
| US-20230073504-A1 | METHOD FOR FABRICATING NANO-PARTICLE HAVING PEROVSKITE CRYSTALLINE STRUCTURE AND RESIN COMPOSITION INCLUDING THE NANO-PARTICLE | KOREA INSTITUTE OF MACHINERY & MATERIALS (KR) | 2023-03-09 | — | — | US | claimed |
| CN-115254009-A | Preparation method of blood perfusion device filler for reducing uric acid concentration | 江苏恰瑞生物科技有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-113874318-A | Method for obtaining mesoporous silica particle-supported metal oxide | 柏林工业大学 | 2021-12-31 | — | — | CN | claimed |
| CN-107753464-B | Hollow silica nanoparticles encapsulating bioactive components, methods of making and uses thereof | 牟中原 | 2021-11-16 | — | — | CN | claimed |
| CN-113499319-A | Hollow silica nanoparticles encapsulating bioactive components, methods of making and uses thereof | 牟中原 | 2021-10-15 | — | — | CN | claimed |
| CN-111870699-A | Surface-modified mesoporous silica nanoparticles, method for producing same, and use thereof | 奈力生医股份有限公司 | 2020-11-03 | — | — | CN | claimed |
| EP-2669269-B1 | NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS | UNIV NORTH CAROLINA CHAPEL HILL (US) | 2019-05-22 | — | — | EP | claimed |
| US-20100147515-A1 | SURFACE MODIFICATION FOR CROSS-LINKING OR BREAKING INTERACTIONS WITH INJECTED FLUID | SCHLUMBERGER TECHNOLOGY CORPORATION | 2010-06-17 | — | — | US | claimed |
| WO-2009069959-A2 | A NANOPARTICLE FOR SEPARATING PEPTIDE, METHOD FOR PREPARING THE SAME, AND METHOD FOR SEPARATING PEPTIDE USING THE SAME | KOREA UNIVERSITY INDUSTRIAL & ACADEMIC COLLABORATION FOUNDATION (KR) | 2009-06-04 | — | — | WO | claimed |
| US-20090087381-A1 | CHELATOR-FUNCTIONALIZED NANOPARTICLES | GENERAL ELECTRIC COMPANY (US) | 2009-04-02 | — | — | US | claimed |
| US-6733828-B2 | Method of fabricating nanostructured materials | NATIONAL TSING HUA UNIVERSITY (TW) | 2004-05-11 | — | — | US | claimed |
| US-20040028913-A1 | Cation-conducting or proton-conducting ceramic membrane based on a hydroxysilylic acid, method for the production thereof and use of the same | HENNIGE VOLKER (DE) | 2004-02-12 | — | — | US | claimed |
| US-20030191205-A1 | MOLECULARLY-IMPRINTED MATERIAL MADE BY TEMPLATE-DIRECTED SYNTHESIS | MARKOWITZ MICHAEL A (US) | 2003-10-09 | — | — | US | claimed |
| US-20030139483-A1 | Molecularly-imprinted material made by template-directed synthesis | NAVY, SECRETARY OF THE, THE UNITED STATES OF AMERICA AS, REPRESENTED BY THE | 2003-07-24 | — | — | US | claimed |
| US-20020065334-A1 | Molecularly-imprinted material made by template-directed synthesis | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY, THE | 2002-05-30 | — | — | US | claimed |
| US-6221944-B1 | SURFACE TREATMENT | EMORY UNIVERSITY | 2001-04-24 | — | — | US | claimed |
| EP-0669385-B1 | USE OF SILICONE RELEASE AGENT | DOW CORNING (US) | 1999-07-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090087381-A1 | CHELATOR-FUNCTIONALIZED NANOPARTICLES | SLC40A1, TFRC, SLC19A1 | TYMS 1582/4885LPAR3 4062/4885LPAR2 4344/4885 |
| US-20030139483-A1 | Molecularly-imprinted material made by template-directed synthesis | POLM, SGMS1, MSI2 | TYMS 2966/4885LPAR3 557/4885LPAR2 694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.